Dong, Brian
Lusen, Rita
Chick, Ella
Kline, Lisa
Funding for this research was provided by:
Pfizer
Article History
Received: 17 March 2023
Accepted: 25 May 2023
First Online: 29 September 2023
Declarations
:
: Brian Dong has served on an advisory board and received consulting fees from Pfizer. Rita Lusen and Ella Chick report compensation from pharmaceutical companies to Breastcancer.org for their participation on a number of breast cancer patient advisory boards; payment for time to review a podcast script, patient-facing materials, and websites; and grants from Pfizer and other industry partners for Breastcancer.org to create patient-education materials. Lisa Kline has nothing to disclose.
: This article does not contain any new studies with human participants or animals performed by any of the authors.
: Editorial support was provided by Mahesh Chemudupati, PhD, and Diana Avery, PhD, of Oxford PharmaGenesis Inc., and was funded by Pfizer.